Introduction
Anxiety disorders are common mental disorders that share extreme or pathological anxiety as the primary disturbance in mood or emotional tone [1] . Common denomination of all anxiety disorders is a state of increased fear and exaggerated version of the acute stress response [2] . Literature revealed a link between anxiety and problems with the regulation of various neurotransmitters. The large numbers of neurotransmitters, peptides, hormones, and other neuromodulators have been implicated in fear and anxiety [3] . 5 -HT pathway originating from the dorsal raphe nucleus (DRN) and innervating the amygdala and frontal cortex facilitates conditioned fear. Selective 5-HT reuptake inhibitors (SSRIs) and 5-HT 1A or 5-HT 3 receptorselective drugs can have anti-anxiety effects in certain anxiety disorders and animal models [4] . Several preclinical studies have shown that stress and anxiety cause a marked increase in NA release in several rat brain regions, including the hypothalamus, the amygdala, and the LC. 毭 -Aminobutyric acid (GABA) is the most abundant inhibitory neurotransmitter in the brain. The GABA Abenzodiazepine receptor is an important target for several anxiolytic drugs and may therefore play an important role in anxiety-related disorders [5] . It is well reported that Diazepam, GABA A -benzodiazepine receptor agonist at the dose of 2 mg/kg, i.p. significantly showed antianxiety activity in various behavioural paradigms of animals [6] . Several studies have shown that positive allosteric modulators (which potentiate GABA action), such as progesterone and allopregnanolone, have anxiolytic effects in various animal models [7] . Several peptides, such as cholecystokinin (CCK), neuro-peptide Y (NPY), tachykinins (substance P, neuro-kinins A and B), and natriuretic peptides (atrial natriuretic peptide or C-type natriuretic peptide) may play important roles in fear and anxiety-related behaviors [8] . There is increasing evidence that NO may underlie anxiety in the elevated plus-maze test, an animal model of anxiety. NO analogues have been found to reduce GABA-gated current via cGMP-dependent pathways, leading to anxiety [9] . cGMP downregulates GABA receptor function in hippocampus, an important area involved in anxiety [10] . The elevated plus-maze (EPM) two closed arms [11, 12] . This test is rapid and was found to be sensitive to the effects of both anxiolytic and anxiogenic agents. The Light/Dark exploration test (LDT) is another commonly used model for anxiety [13] , devised by Crawley [14] , this test is based on the innate aversion of rodents to brightly illuminated areas and on the spontaneous exploratory behaviour of rodents in response to mild stressors, i.e. novel environment and light. The LDT has been widely adopted as an anxiolytic screening test in mice [15] . Thymol (2-isopropyl-5-methylphenol) is naturally occurring phenolic monoterpene derivative of cymene, which is found in the oils of thyme and plants such as Thymus vulgaris [16] , Thymus glandulosus [17] , Thymus hyemalis [18] , Thymus zygis [19] . It exhibits multiple biological activities: antibacterial [20] , antifungal [21] , anti-oxidant [22] , free radical scavenging [23] and anti-lipid peroxidative [24] properties. Thymol was also shown to have strong anti-inflammatory action by decreasing the release of inflammaroty metabolites like prostanoids, interleukins and leukotrienes [25, 26] . Thymol acts as a GABA A receptor agonist/modulator [27] .
Materials and methods

Animals
Swiss albino mice of either sex (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) g) were employed in the present study. Animals were procured from Disease Free Small Animal House, LLRUVAS, Hisar, Haryana, India. Animals were provided normal diet and water ad libitum and were exposed to natural light and dark cycle at controlled room temperature of 20-25 曟 . The animals were acclimatized to the laboratory condition before experiments. The animals were kept fasted 2 h before drug administration, all the behavioral paradigm ware performed during day time between 9 a.m. and 2 p.m. [28] . Experimental 
Drugs and chemicals
Thymol, Diazepam, Ethanol and Sodium chloride were used in this study. Thymol, was procured from Central Drug House (CDH) Ltd. India. Diazepam (Calmpose®); Ranbaxy Laboratories, Ltd., Gurgaon, India. Normal saline (0.9% NaCl) was used as vehicle for Diazepam while absolute ethanol solution (0.01%) was used as vehicle for Thymol. Volume of injection for mouse was 10 mL/kg.
Selection of doses
Doses were selected on the basis of literature, i.e., Thymol (5, 10, 20 [29] .
Behavioral paradigms 2.4.1. Elevated plus maze
The elevated plus maze (EPM) was first proposed as an animal model of anxiety by Handley and Mithani [30] . Elevated [28] . Maze was washed thoroughly with 5% ethanol after each observation to remove odor [31] . Percent 
Light/ dark test
The light/dark test (LDT) model was first described by the Crawely and Goodwin [32] . The apparatus consisted of rectangular shaped box (45 cm伊27 cm伊27 cm) partition into two compartments connected by a 7.5 cm伊7.5 cm opening in the wall between the compartments. An animal was placed in the centre of the light compartment face toward opening of the wall and observed for 5 min, for time spent in open (white/light) compartment. Apparatus was thoroughly washed with 5% ethanol after each observation to remove odor [31] . Percent of time spent by mice in light area was calculated as follows: % = Number of seconds spent in light compartment 300 total sec (5 min observation time) 伊100
Experimental protocol
There were six group of mice used in this study. Each group consisted of five mice. Behavior testing was performed carefully in stepwise manner i.e. mice in each group were subjected to maximum two behavioral tests of anxiety, one followed by another to minimize the stress, that may arise from continuous exposure to these paradigms. Doses and routes of administration of drugs were selected according to previous studies as reported in the literature. All treatments (vehicle, 10 mL/kg; Thymol 5, 10 and 20 mg/kg; Daizepam 2 mg/kg) were administered intraperitoneally (i.p.) in a fixed volume of 1 mL/100 g body weight in separate groups of mice. Behavior testing was performed i.e. drug was given to each animal, after 30 min behavior testing was performed in EPM and LDT.
Statistical analysis
All the results were expressed as mean依SEM. All statistical analysis was done using one way analysis of variance (ANOVA) followed by the Tukey's post hoc test. P<0.05 was considered as significant when compared to their respective control group.
Results
In elevated plus maze and light/dark test, significant increase in percentage of time spent in open arms and significant increase in percentage of time spent in light compartment indicate anxiolytic-like effect respectively. On the other hand, significant decreased in above parameters indicates anxiogenic effect. 
Effect of different drug treatments on mice behavior in elevated plus maze
Effect of different drug treatments on mice behavior in light/dark test
Diazepam significantly increased percentage of time spent in light compartment of light/dark test. Thymol (20 mg/kg) significantly increased percentage of time spent in light compartment of light/dark test as compared to vehicle (0.01% ethanol) treated mice. Therefore thymol (20 mg/kg) produced significant anti-anxiety effect as compared to vehicle (0.01% ethanol) treated mice (Table 2; Figure 2 ). 
Conclusion
Elevated plus maze (EPM) and Light/dark test box (LDT) are two best models of anxiety. These both come under ethologically based animal models of fear and anxiety and involves the animal's spontaneous or natural reactions (e.g. flight, avoidance and freezing) to stress stimuli that do not explicitly involve pain or discomfort [33] . In the present study, only thymol 20 mg/kg dose produced significant anti-anxiety like activity among its three doses. Diazepam binds to a specific subunit on the GABA A receptor at a site distinct from the binding site of the endogenous GABA molecule, known as an allosteric site. The GABA A receptor is an inhibitory channel which, when activated, decreases neuronal activity. Benzodiazepines cause an increased opening of the chloride ion channel when GABA binds to its site on the GABA A receptor, leading to more chloride ions entering the neuron, which in turn leads to enhanced central nervous system depressant effects [34] . Thymol is a positive allosteric modulator of the GABA A receptor [35] . The GABAmodulating and GABA-mimetic activities of thymol on human GABA A and fruitfly (Drosophila melanogaster Meig.) homomeric RDLac GABA A receptors expressed in Xenopu oocytes. Thymol enhanced the GABA-dependent chloride currents in oocytes expressing various human GABA A receptor isoforms as well as the insect GABA A receptor [36] . It has been observed that NO donors produce 5-HT release in a biphasic way, with low concentrations of NO donors decreasing 5-HT release in the hypothalamus and high concentrations increasing it. Both effects are mediated by cGMP [37] . There is evidence suggesting the role of NO/cGMP signaling pathway in effect of NO on anxiety [38] . Inhibition of NO/cGMP signaling pathway by inhibiting of NOS has been reported to produce anti-anxiety effect [39] . Thymus vulgaris oil showed a significant decrease in aflatoxin-induced increased production of NO in liver and kidney proved its NO modulating anti-oxidant activity [40] . Thymus vulgaris extract significantly inhibit the enhanced production of NO, induced by LPS and INF-毭 in a dose dependent manner [41] . Final conclusion of this study is that, the anti-anxiety like activity of thymol may through possible modulation of GABA pathway or/and NO-cGMP pathway or/and 5-HT pathway. Further study is needed to explore the precise mechanism in anxiety by the Thymol.
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